PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients

Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00581945 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)

NCT00549445 ·Status: COMPLETED

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

NCT02968212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

NCT05846230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

NCT00128492 ·Status: COMPLETED ·Phase: PHASE3

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

NCT04871815 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

NCT01793649 ·Status: TERMINATED ·Phase: PHASE1

A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis

NCT02950805 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

NCT01661244 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics of SPL84 in Healthy Volunteers

NCT06217952 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease

NCT01322594 ·Status: COMPLETED ·Phase: PHASE1

Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection

NCT02102152 ·Status: UNKNOWN ·Phase: NA

Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients

NCT02483637 ·Status: COMPLETED ·Phase: NA

Effects of CSL324 in the Lung After Segmental Challenge

NCT05653713 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure

NCT06746064 ·Status: COMPLETED ·Phase: PHASE1

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

NCT05181397 ·Status: UNKNOWN ·Phase: PHASE2

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

NCT01641822 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

NCT00104520 ·Status: COMPLETED ·Phase: PHASE3

A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT01872689 ·Status: COMPLETED ·Phase: PHASE2

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

NCT03449459 ·Status: COMPLETED ·Phase: EARLY_PHASE1

N-Acetylcysteine for Patients With COPD and ChronicBronchitis

NCT01599884 ·Status: UNKNOWN ·Phase: NA

Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis

NCT02035488 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

NCT05865886 ·Status: COMPLETED ·Phase: PHASE2

PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients

NCT01187589 ·Status: COMPLETED ·Phase: NA

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

NCT04901455 ·Status: COMPLETED ·Phase: EARLY_PHASE1